Das Endometriumkarzinom

Günter Emons

doi:10.1055/s-0033-1358094

Frauenheilkunde up2date, Table of Contents

Frauenheilkunde up2date 2015; 9(1): 19-34
DOI: 10.1055/s-0033-1358094

Gynäkologische Endokrinologie und Reproduktionsmedizin

Georg Thieme Verlag KG Stuttgart · New York

Das Endometriumkarzinom

Günter Emons

Abstract

All articles of this category

Full Text

References

Literatur
1 Kommission Uterus der Arbeitsgemeinschaft Gynäkologische Onkologie e. V.. Interdisziplinäre S2 k-Leitlinie für die Diagnostik und Therapie des Endometriumkarzinoms. In: Kommission Uterus der Arbeitsgemeinschaft Gynäkologische Onkologie e. V. in der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe e. V. sowie in der Deutschen Krebsgesellschaft e.V., Hrsg. Leitlinien zum Zervixkarzinom, zum Endometriumkarzinom und zu den Trophoblasttumoren. München: W. Zuckschwerdt Verlag; 2008: 73-126
2 Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V. Hrsg. Krebs in Deutschland 2009/2010. 9. Ausgabe. Berlin: RKI; 2013
3 Burke WM, Orr J, Leitao M et al. SGO Clinical Practice Endometrial Cancer Working Group. Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol 2014; 134: 385-392
4 Burke WM, Orr J, Leitao M et al. SGO Clinical Practice Endometrial Cancer Working Group. Endometrial cancer: a review and current management strategies: part II. Gynecol Oncol 2014; 134: 393-402
5 Ward KK, Roncancio AM, Shah NR et al. The risk of uterine malignancy is linearly associated with body mass index in a cohort of US women. Am J Obstet Gynecol 2013; 209: 579.e1-579.e5
6 van Meurs HS, Bleeker MC, van der Velden J et al. The incidence of endometrial hyperplasia and cancer in 1031 patients with a granulosa cell tumor of the ovary: long-term follow-up in a population-based cohort study. Int J Gynecol Cancer 2013; 23: 1417-1422
7 Setiawan VW, Yang HP, Pike MC et al. Type I and II endometrial cancers: have they different risk factors?. J Clin Oncol 2013; 31: 2607-2618
8 Vasen HF, Blanco I, Aktan-Collan K et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 2013; 62: 812-823
9 Zaino R, Carinelli SG, Ellenson LH et al. Tumours of the uterine corpus: Epithelial Tumours and Precursors. In: Kurman RJ, Carcanglu ML, Herrington CS, Young RH, Hrsg. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon: WHO Press; 2014: 125-135
10 Antonsen SL, Ulrich L, Hogdall C. Patients with atypical hyperplasia of the endometrium should be treated in oncological centers. Gynecol Oncol 2012; 125: 124-128
11 Kommission Uterus der Arbeitsgemeinschaft Gynäkologische Onkologie e. V.. Empfehlungen für die Diagnostik und Therapie des Endometriumkarzinoms. Aktualisierte Empfehlungen der Kommission Uterus auf Grundlage der S2 k Leitlinie (Version 1.0, 1.6.2008) ohne Angabe der Evidenzlevel und Empfehlungsgrade. April 2013; http://www.ago-online.org Im Internet: http://www.ago-online.org Stand: 01.01.2015
12 NCC Clinical Practice Guidelines in Oncology. Uterine Neoplasma, Version 1.2014. Im Internet:. http://www.NCCN.org Stand: 20.10.2014
13 Kandoth C, Schultz N, Cherniack AD et al. The Cancer Genome Atlas Network. Integrated genomic characterization of endometrial carcinoma. Nature 2013; 497: 67-73
14 ACOG Committee Opinion No. 426: The role of transvaginal ultrasonography in the evaluation of postmenopausal bleeding. Obstet Gynecol 2009; 113: 462-464
15 Jacobs I, Gentry-Maharaj A, Burnell M et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol 2011; 12: 38-48
16 Vergote I, Amant F, Timmerman D. Should we screen for endometrial cancer?. Lancet Oncol 2011; 12: 4-5
17 Wittekind CJ, Meyer HJ. Gynäkologische Tumoren. Uterus Endometrium. In: Wittekind CJ, Meyer HJ, Hrsg. TNM Klassifikation maligner Tumoren. 7. Aufl. Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA; 2010: 198-201
18 Emons G, Cimin-Bredée N. Abnorme uterine Blutungen. Frauenheilkunde up2date 2011; 5: 357-367
19 Trimble CL, Method M, Leitao M et al. Management of endometrial precancers. Obstet Gynecol 2012; 120: 1160-1175
20 Emons G. Significance of lymph node dissection in gynecological oncology. Oncol Res Treat 2014; 37: 500-504
21 Dowdy SC, Borah BJ, Bakkum-Gamez JN et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer. Gynecol Oncol 2012; 127: 5-10
22 Todo Y, Kato H, Kaneuchi M et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010; 375: 1165-1172
23 Takano M, Ochi H, Takei Y et al. Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?. Br J Cancer 2013; 109: 1760-1765
24 Galaal K, Bryant A, Fisher AD et al. Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev 2012; (9) CD006655
25 Kong A, Johnson N, Kitchener HC et al. Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev 2012; (3) CD003916
26 Onsrud M, Cvancarova M, Hellebust TP et al. Long-term outcomes after pelvic radiation for early-stage endometrial cancer. J Clin Oncol 2013; 31: 3951-3956
27 Johnson N, Bryant A, Miles T et al. Adjuvant chemotherapy for endometrial cancer after hysterectomy. Cochrane Database Syst Rev 2011; (10) CD003175
28 Wright JD, Barrena Medel NI, Sehouli J et al. Contemporary management of endometrial cancer. Lancet 2012; 379: 1352-1360
29 Miller D, Filiaci V, Flemming G et al. Late-Breaking Abstract 1: Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 2012; 125: 771-773